Navigation Links
Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities
Date:2/1/2010

BANGALORE, India, February 1 /PRNewswire/ -- Infinitus Clinical Research is continuing to pioneer its unique strategy. This is based on the following elements:

    - Physician leadership
    - Employee ownership
    - Sino-Indian focus
    - Flexible co-development model availability
    - Experience of big Pharma drug development programme planning
    - Experience of early stage life science company product development
    - Phase I, II and III capability within Asia for clinical evaluation of
      drugs
    - Clinical evaluation of medical devices
    - Clinically focused bioinformatics capability
    - Unique academic links and collaborations

"As former Vice-President for clinical drug development with a major US Pharma company" said CEO, Roy Drucker, "I was frustrated by the unexploited potential of India and China. Large Western CROs were inevitably forced to give up part of the cost advantage of those countries because of operating expense back at base camp. The best local players scored better on price and satisfied study deadline requirements but were incapable of assuming a product development partnership role. We strive to deliver the best of both worlds at Infinitus. "

"Our conviction that excellent medical science underpins excellent clinical research is reflected in our European headquarters location in the Department of Pharmacology at Oxford University. We recognize that a significant part of our client base is in the USA and our North American office will open shortly. We are also progressing a major oncology initiative which will enable Infinitus to deliver unparalleled speed, quality and prices for studies in all phases."


'/>"/>

SOURCE Infinitus Clinical Research Pvt. Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sequenom Announces Addition to Clinical Advisory Board
2. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
3. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
4. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
5. Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients
6. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
7. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
8. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
9. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
10. Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
11. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
(Date:7/10/2014)... R.I. , July 10, 2014 CVS Caremark ... board of directors has approved a quarterly dividend of $0.275 ... dividend is payable on August 1, 2014, to holders of ... CVS Caremark is dedicated to helping people ... pharmacy company in the United States . ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... today,announced that the United States Food and Drug ... for the treatment of pulmonary,arterial hypertension (PAH). Terguride ... Phase II trial in Europe., "The FDA,s ... PAH,encourages and strengthens our development program by offering ...
... Tigris Pharmaceuticals,Inc. announced today the execution of a ... Cancer Institute (NCI) to,collaborate on clinical and preclinical ... development. AFP-464 is converted to,metabolites which bind covalently ... This is part of a four-year CRADA encompassing ...
Cached Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3
(Date:7/12/2014)... Albany, NY (PRWEB) July 12, 2014 ... to 2020 - New and Late-Stage Four-Factor PCCs ... in-depth analysis of the critical care market in ... and Canada. The report provides an estimation of ... to 2020. It covers critical care indications that ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 As reported in ... Institute of Standards and Technology), the June 25th, 2014 Supreme ... electronic discovery world. It was also met with ... depending on whether it was seen from an individual privacy ... much is fact, there is now precedent which will require ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Dubai is ... basketball legend is heading to the UAE. The ... champion will be in the UAE from 28-31 October ... in support of diabetes awareness. The event is being ... marketing and event management company based in Dubai. The ...
(Date:7/12/2014)... 12, 2014 Praeclarus Press ... as a valuable new resource for women in need ... American women work away from their children. Today’s mothers ... benefits of breastfeeding, but often feel unsupported when it ... babies. With its evidence-based insights, and written by Nancy ...
(Date:7/12/2014)... July 12, 2014 Restore My Vision ... and Samantha Pearson, a couple boasting very impressive credentials ... Restore My Vision Today as a way to help ... have become in their respective patients’ treatments . ... to a “secret” trove of pertinent information relevant to ...
Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 3
... Antibiotic resistance is one of the biggest problems worldwide. ... be developed to fight these new antibiotic resistant infections. ... at Colney in Norfolk say they have used natural ... infections. Researchers said the discovery would allow scientists race ...
... used for treating obstructive sleep apnea patients, by making them ... resolving heart abnormalities, says Belgium physicians. // ,OSA ... ,"Not only are the shape and size ... was dilated and the heart muscle on the left side ...
... has been long regarded to be a chronic and unremitting ... temporary or short-lived condition // from which affected individuals can ... the same thing about alcohol. But now I think that ... what compulsive gambling is - for some people it is ...
... the NHS Heath Scotland, has had its lines choked with ... in Scotland since Sunday, last. // The line which ... fold increase of almost 450 calls a day, post ban ... flow of calls. This is a shot in the arm ...
... of the European Commission would be targeted towards controlling ... and malaria // that are haunting the Asian region. ... and TB through External Action' would be launched neat ... aimed at reducing the financial constraints that prevent the ...
... syndrome (PTSD) is a disabiling anxiety disorder, which was ... World War I, as soldier's heart and shell shock ... who are affected by cancer and their families as ... PTSD affects about 10 percent of those exposed to ...
Cached Medicine News:Health News:Compulsive Gambling Not A Chronic Addiction Always: Research 2Health News:Control And Prevention Of Three Diseases To Be Discussed: European Commission 2Health News:New Therapy For Treating Post-Traumatic Stress Syndrome 2
... Designed to inform decision ... complete patient data on demand. ... access to lab results, medication ... allergy profiles, and clinical notes ...
... The SJM Tailor Flexible Band ... a convenient and time-saving alternative for ... It complements the SJM Tailor® Annuloplasty ... who usually implant full rings, but ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
... from Thermo Labsystems was designed specifically to ... features such as the new fast dial ... microvolumes help to define this as a ... new interchangeable handle plate offers a custom ...
Medicine Products: